• In late June 2026, RLI Corp. was removed as a constituent from multiple Russell growth and small/mid-cap benchmarks, including the Russell 1000 Growth, 2500 Growth, 3000 Growth, 3000E Growth, Midcap Growth, and related defensive and small-cap composite indexes.
• On top of this broad index removal, the recent resignation of director Michael Angelina to pursue another board role adds a governance change that investors may weigh alongside potential shifts in RLI’s shareholder base and trading liquidity.
• Next, we’ll examine how RLI’s removal from several Russell growth indexes may influence its existing investment narrative and risk profile.

Outshine the giants: these 15 early-stage AI stocks could fund your retirement.

RLI Investment Narrative Recap

To own RLI today, you need to believe its underwriting discipline and niche specialty focus can continue to support attractive profitability, even as growth expectations moderate and the stock trades at a premium to many insurance peers. The recent removal from multiple Russell growth indexes is unlikely to change the core business thesis in the near term, but it may heighten the short term risk around trading liquidity and ownership shifts, especially given already cautious earnings forecasts.

Among recent announcements, the new US$250 million share repurchase authorization and US$2.00 per share special dividend in May 2026 stand out in light of the index removals. Together, they signal management’s willingness to return capital and potentially offset some selling pressure if index-linked investors reduce positions. For shareholders focused on catalysts, these payout moves sit alongside RLI’s strong recent earnings and high return on equity, but they also raise questions about future capital flexibility if conditions become more challenging.

Yet beneath these reassuring capital returns, there is an important risk around shifting shareholder mix and liquidity that investors should be aware of...

RLI’s narrative projects $1.8 billion revenue and $318.9 million earnings by 2029.

Uncover how RLI's forecasts yield a $58.00 fair value, in line with its current price.

Exploring Other Perspectives

Lowest estimate analysts take a much harsher view, assuming earnings fall toward about US$218.8 million on roughly flat US$1.9 billion revenue, so this index removal could either reinforce or challenge that more pessimistic story depending on how ownership and pricing behavior evolve from here.

Explore 2 other fair value estimates on RLI - why the stock might be worth just $56.85!

Decide For Yourself

Disagree with existing narratives? Extraordinary investment returns rarely come from following the herd, so go with your instincts.

• A great starting point for your RLI research is our analysis highlighting 2 key rewards and 2 important warning signs that could impact your investment decision.
• Our free RLI research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate RLI's overall financial health at a glance.

Seeking Other Investments?

Markets shift fast. These stocks won't stay hidden for long. Get the list while it matters:

• The future of work is here. Discover the 29 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.
• We've uncovered the 9 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.
• AI is about to change healthcare. These 41 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.